Gold salt in the treatment of bronchial asthma--a double-blind study. 1978

M Muranaka, and T Miyamoto, and T Shida, and J Kabe, and S Makino, and H Okumura, and K Takeda, and S Suzuki, and Y Horiuchi

The efficacy of gold salt on bronchial asthma was investigated by double-blind design in 79 patients. The rate of improvement was significantly higher in the gold-treated group (20/28) than in the controls (16/36). This was reflected by greater reduction of requirement for symptomatic medications. Only mild side effects were observed in 14 patients out of 38 gold-treated patients.

UI MeSH Term Description Entries
D008297 Male Males
D011507 Proteinuria The presence of proteins in the urine, an indicator of KIDNEY DISEASES. Proteinurias
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females
D005541 Forced Expiratory Volume Measure of the maximum amount of air that can be expelled in a given number of seconds during a FORCED VITAL CAPACITY determination . It is usually given as FEV followed by a subscript indicating the number of seconds over which the measurement is made, although it is sometimes given as a percentage of forced vital capacity. Forced Vital Capacity, Timed,Timed Vital Capacity,Vital Capacity, Timed,FEVt,Capacities, Timed Vital,Capacity, Timed Vital,Expiratory Volume, Forced,Expiratory Volumes, Forced,Forced Expiratory Volumes,Timed Vital Capacities,Vital Capacities, Timed,Volume, Forced Expiratory,Volumes, Forced Expiratory
D006052 Gold Sodium Thiomalate A variable mixture of the mono- and disodium salts of gold thiomalic acid used mainly for its anti-inflammatory action in the treatment of rheumatoid arthritis. It is most effective in active progressive rheumatoid arthritis and of little or no value in the presence of extensive deformities or in the treatment of other forms of arthritis. Aurothiomalate,Gold Thiomalate,Sodium Gold Thiomalate,Aurolate,Gold Disodium Thiomalate, Monohydrate,Gold Thiomalic Acid,Mercaptobutanedioic Acid Monogold(1+) Sodium Salt,Miocrin,Miocrisin,Monogold (1+) Disodium Thiomalate,Myochrysine,Myocrisin,Myocrysine,Sodium Aurothiomalate,Sodium Thiomalatoaurate,Tauredon,Aurothiomalate, Sodium,Gold Thiomalate, Sodium,Sodium Thiomalate, Gold,Thiomalate, Gold,Thiomalatoaurate, Sodium
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001249 Asthma A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL). Asthma, Bronchial,Bronchial Asthma,Asthmas

Related Publications

M Muranaka, and T Miyamoto, and T Shida, and J Kabe, and S Makino, and H Okumura, and K Takeda, and S Suzuki, and Y Horiuchi
December 1972, Acta allergologica,
M Muranaka, and T Miyamoto, and T Shida, and J Kabe, and S Makino, and H Okumura, and K Takeda, and S Suzuki, and Y Horiuchi
June 1979, The Indian journal of medical research,
M Muranaka, and T Miyamoto, and T Shida, and J Kabe, and S Makino, and H Okumura, and K Takeda, and S Suzuki, and Y Horiuchi
March 1991, The Medical journal of Australia,
M Muranaka, and T Miyamoto, and T Shida, and J Kabe, and S Makino, and H Okumura, and K Takeda, and S Suzuki, and Y Horiuchi
January 1966, The American review of respiratory disease,
M Muranaka, and T Miyamoto, and T Shida, and J Kabe, and S Makino, and H Okumura, and K Takeda, and S Suzuki, and Y Horiuchi
June 1973, Polskie Archiwum Medycyny Wewnetrznej,
M Muranaka, and T Miyamoto, and T Shida, and J Kabe, and S Makino, and H Okumura, and K Takeda, and S Suzuki, and Y Horiuchi
March 1973, Schweizerische medizinische Wochenschrift,
M Muranaka, and T Miyamoto, and T Shida, and J Kabe, and S Makino, and H Okumura, and K Takeda, and S Suzuki, and Y Horiuchi
October 1994, Ugeskrift for laeger,
M Muranaka, and T Miyamoto, and T Shida, and J Kabe, and S Makino, and H Okumura, and K Takeda, and S Suzuki, and Y Horiuchi
March 1972, The Journal of asthma research,
M Muranaka, and T Miyamoto, and T Shida, and J Kabe, and S Makino, and H Okumura, and K Takeda, and S Suzuki, and Y Horiuchi
August 1998, Clinical pharmacology and therapeutics,
M Muranaka, and T Miyamoto, and T Shida, and J Kabe, and S Makino, and H Okumura, and K Takeda, and S Suzuki, and Y Horiuchi
October 1971, Canadian Medical Association journal,
Copied contents to your clipboard!